Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBGL Cannabis Global Completes Significant Debt Cancellations in Q1 - Over $800K in Debt Extinguishment - Actively Negotiating Additional Debt Settlements
https://feeds.issuerdirect.com/news-release.html?newsid=7256443189477382
$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$AVOI New Owners- Shell Just Bought bet we see a good merger/acquisition soon here
New owners paid $305,000 for it I believe they have big plans for AVOI
Clean Company, Zero Debt. Funds used to buy company were used to pay off all the debt of the company.
$IVDN News: Innovative Designs Receives Patent for Propriety Process With Low Density Foam
Pittsburgh, PA, April 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Innovative Designs (IVDN) is pleased to announce that on April 11, 2023, the United States Patent and Trademark Office (USPTO) has issued Patent # 11,623.375 B2 defining our proprietary process for forming closed and evacuated cell expanded low density foam is entitled to patent protection. The USPTO first issued in January 2023 a Notice of Allowance and the patent was issued accordingly.
Innovative Designs CEO Joseph Riccelli commented, "This is a key milestone and validation for our Insultex(R) insulation. Now that this patent is in place, we anticipate unprecedented growth into apparel and many other markets."
Disclaimer - Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov.
Joseph Riccelli
412-799-0350
joer@idigear.com
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
VIRI 111M VOLUME 10 DAY AVG_1.4M .97 +55.14%
*HOD $1.44
$EMED During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.
$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.
$GMPR Twriiter Update on successful sales of the company's popular Pizza Fusion products at the Sprankle’s Grocery chain...
Pizza Fusion@PizzaFusion
Sprankle’s Grocery stores, located in western PA, have been selling our 3 Gourmet
@PizzaFusion
#GlutenFree pizzas for 2 years. They do fun weekly videos for their many loyal customers, here is one they posted earlier today on their Facebook page $GMPR
Twitter Link:
Sprankle’s Grocery stores, located in western PA, have been selling our 3 Gourmet @PizzaFusion #GlutenFree pizzas for 2 years. They do fun weekly videos for their many loyal customers, here is one they posted earlier today on their Facebook page $GMPR pic.twitter.com/dztKEJ5L5L
— Pizza Fusion (@PizzaFusion) March 17, 2023
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
Yes… I’m out of trading but definitely hope all is well.
PPCB.... This is the stock to buy today. News about cancer treatments.. Could be looking at a merger with a huge drug company if so. https://www.propanc.com/news-media/press-releases/detail/146/propanc-biopharma-confirms-prp-exerts-significant-effects
agreed hope all is well!
Let’s get Spring going!
Where have you been hiding bro?
$VRVR News: Virtual Interactive Technologies Corp. Launches All New, State of the Art Website to Showcase its Category-First Metaverse and Other Gaming Experiences
Click here:
https://www.prnewswire.com/news-releases/virtual-interactive-technologies-corp-launches-all-new-state-of-the-art-website-to-showcase-its-category-first-metaverse-and-other-gaming-experiences-301708489.html
$PVSP The current team has cleaned up the business.
$GBHL
$PVSP PERVASIP is in the process of looking for other opportunities to create value.
$GBHL
$PVSP The current team has cleaned up the business.
$GBHL
$PVSP The company WILL announce various opportunities.
$GBHL
$PVSP PERVASIP is in the process of looking for other opportunities to create value.
$GBHL
$PVSP The current team has cleaned up the business.
$PVSP PERVASIP is in the process of looking for other opportunities to create value.
$PVSP The current team has cleaned up the business.
$PVSP PERVASIP is in the process of looking for other opportunities to create value.
$SNPW> is " SUPER GOLDEN " https://elbapower.com/
$SNPW #NEWS> https://marketwatch.com/press-release/new-us-solar-plant-with-50-million-insurance-investment-elba-power-marketing-of-clean-energy-devices-with-foxess-sun-pacific-co-stock-symbol-snpw-2023-01-31
* New U.S. Solar Plant with $50M Insurance Investment,
* Also Investment Grade "A " Rating thru Lloyd's of London. icymi
$PVSP The current team has cleaned up the business.
$PVSP Holders of Pervasip’s issued and outstanding common shares as of the record date will receive an aggregate of 15,000,000 shares of Artizen common stock, corresponding to 15% of Artizen’s fully diluted issued and outstanding common shares upon completion of the transaction (in addition to retaining their shares in Pervasip). Likewise, holders of Pervasip’s Series K and other convertible securities will receive an aggregate of 85,000,000 shares of Artizen common stock, the vast majority of which will be subject to lock-up restrictions prohibiting sales prior to Artizen’s realization of material growth and other performance objectives. Artizen will have 100,000,000 common shares outstanding on a fully diluted basis upon completion of the transaction, with no convertible debt or other securities.
$PVSP The current team has cleaned up the business.
$PVSP From the latest release: Burtscher added, “Timing is important. The valuations and fates of MSOs and other participants in the cannabis industry have vacillated in several waves since state legalization commenced. We believe that increased legalization is inevitable in time, both at the federal level and in the form of improved regulatory environments in Washington. Preparing ourselves for that day is an important aspect of our long-term plans, including by expanding our brands and building on our footprint in valuable new geographies, and accessing long term equity capital to do so with shareholder friendly structures. Critically, the Artizen capital structure after the spin-out is completed has been specifically designed to allow us to raise equity financing on terms that vastly exceed anything that we can accomplish with Pervasip’s current capital structure.”
https://www.bloomberg.com/press-releases/2023-01-17/pervasip-corp-pervasip-announces-artizen-spin-off
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off
$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.
https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news
$PVSP From the latest release: Burtscher added, “Timing is important. The valuations and fates of MSOs and other participants in the cannabis industry have vacillated in several waves since state legalization commenced. We believe that increased legalization is inevitable in time, both at the federal level and in the form of improved regulatory environments in Washington. Preparing ourselves for that day is an important aspect of our long-term plans, including by expanding our brands and building on our footprint in valuable new geographies, and accessing long term equity capital to do so with shareholder friendly structures. Critically, the Artizen capital structure after the spin-out is completed has been specifically designed to allow us to raise equity financing on terms that vastly exceed anything that we can accomplish with Pervasip’s current capital structure.”
https://www.bloomberg.com/press-releases/2023-01-17/pervasip-corp-pervasip-announces-artizen-spin-off
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off
Happy & Health New Year bud!!!!
$CEOS rising!!!
Let’s all get it in 2023!
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off
REII - Why Hydrogen is the answer to rapid EV charging - Part One
https://www.renewable-innovations.com/blog/why-hydrogen-is-the-answer-to-rapid-ev-charging
***https://www.barchart.com/stocks/quotes/REII/overview
$CDSG China Dongsheng International, Inc. intends to acquire public and private companies that are engaged in the technology, natural resource, and various other sectors. Currently CDSG is engaged in lithium exploration and mining projects to support the emerging electric vehicle industry.
https://lnkd.in/gguQtQub
Fed Reserve day today. So we may see some market volatility start later today based what they say.
https://www.cnbc.com/2022/12/14/heres-everything-the-federal-reserve-is-expected-to-do-wednesday.html
Followers
|
439
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
27508
|
Created
|
02/26/13
|
Type
|
Free
|
Moderator OCKHAM'S RAZOR | |||
Assistants |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |